Generate Biomedicines
Head of Commercial, Strategy & Execution for Immunology Portfolio
Somerville, MA · Senior
Stay score
odds of building a lasting career here
Thin sponsorship signal and lottery-bound. A low-probability bet with your clock running. Prioritize cap-exempt roles and proven entry-level sponsors first.
Lottery odds assume a STEM candidate.
Personalize to your clock →Employer immigration record
from this employer's Department of Labor filings
Files H-1B transfers
Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.
Community outcomes
No reports yet — be the first to help the next applicant.
About the role
- This senior commercial leader will be primarily responsible for defining and executing Generate's commercial strategy for GB-0895 which is currently in multiple Phase 3 clinical trials in Asthma and moving into late stage clinical development in COPD.
- This individual will bring a strong enterprise mindset and ensure that commercial perspectives are integrated early, rigorously, and pragmatically into program strategy, development planning, and portfolio decisions.
Responsibilities
- The role will also help establish and implement the commercial capability and organizational build in a phase appropriate way to meet the needs of GB-0895 and Generate at large.
- Lead development and ongoing refinement of a multi-year commercialization roadmap for GB-0895, spanning strategic planning, pre-launch capability building, operating model design, and key go-to-market decisions.
- Collaborate with Finance and Strategy to support long-range planning, portfolio prioritization, investment decisions, and program valuation through clear commercial assumptions and data-driven scenarios.
Nice to have
- Represent the commercial perspective in governance forums, program team discussions, and senior leadership reviews, providing clear recommendations, risk assessments, and decision-ready analyses.
- Deep experience in immunology commercialization and a strong grasp of the treatment landscape, competitive dynamics, and stakeholder environment across major immunology markets.
- A demonstrated track record of shaping commercial strategy for development-stage or early-launch assets, with the ability to influence cross-functional teams well before commercialization.
- Experience leading major cross-functional initiatives that connect commercial, clinical, regulatory, and finance stakeholders around a common strategy.
- Strong strategic problem-solving skills, including market assessment, scenario planning, forecasting inputs, investment framing, and executive communication.
This listing is sourced directly from Generate Biomedicines's careers page and normalized into a canonical job model.